Category: Covid-19 Vaccine

Page 300«..1020..299300301302..310320..»

COVID hit this family twice, but vaccines blunted reinfections : Shots – Health News – NPR

November 27, 2021

Three generations, (from left to right) grandmother Genoveva Calloway, daughter Petra Gonzales, and granddaughter Vanesa Quintero, live next door to each other in San Pablo, Calif. Recently their extended family was hit with a second wave of COVID infections a year after the first. Beth LaBerge/KQED hide caption

Three generations, (from left to right) grandmother Genoveva Calloway, daughter Petra Gonzales, and granddaughter Vanesa Quintero, live next door to each other in San Pablo, Calif. Recently their extended family was hit with a second wave of COVID infections a year after the first.

On a Friday afternoon in early October this year, 8-year-old Maricia Redondo came home from her third grade class in the San Francisco Bay Area with puffy eyes, a runny nose and a cough.

"On Saturday morning we both got tested," says Vanessa Quintero, Maricia's 31-year-old mother. "Our results came back Monday that we were both positive."

Vanessa stared at her phone in shock and called her doctor's test-result hotline again, in disbelief. "This is wrong," she thought. "I hung up and dialed again. It's positive. This is wrong. I hung up again. And then I did it again!"

She was freaking out for two reasons. First, her large, extended family had already fought a harrowing battle against COVID-19 last year in the fall of 2020. The virus had traveled fast and furious through their working class neighborhood back then, in the East Bay city of San Pablo. Four generations of Vanessa's family live next door to each other in three different houses there, all connected by a backyard.

Vanessa was also terrified because she couldn't fathom another round of treatment against a more dangerous variant than she'd faced before. The pandemic has disproportionately struck Latino families across the United States, and delta is currently the predominant variant in the U.S., according to the U.S. Centers for Disease Control and Prevention. It's twice as contagious and may cause more severe illnesses than previous variants in unvaccinated people.

The family's bad luck was uncanny. Research suggests immunity against a natural infection lasts about a year. And here it was almost exactly the same time of year and the family was fighting COVID-19 again.

"Reinfection is a thing," says Dr. Peter Chin-Hong, a specialist in infections diseases and professor of medicine at the University of California, San Francisco. "It probably manifests itself more when the variant in town looks different enough from the previous variants. Or enough time has elapsed since you first got it, [and] immunity has waned." He says a second infection is still not common, but doctors are starting to see more cases.

Computer models in a recent study suggest that people who have been infected by the virus can expect a reinfection within a year or two if they do not wear a mask or receive a vaccination. The findings show that the risk of a second bout rises over time. A person has a 5% chance of catching the virus four months after an initial infection, but a 50% chance 17 months later.

"The second time it was scarier because I'm vaccinated," says Vanessa referring to the family's second bout with the virus in October 2021. "Her dad's vaccinated. We're protected in that sense, but she's [Maricia] not."

Her 8-year-old daughter was still too young to qualify for a vaccine. This fall the little girl lay in bed wheezing. Vanessa tripled down on Maricia's asthma medication and the parents quarantined themselves inside, too. Vanessa shuddered at the prospect of telling her mother and grandma about a second round of positive test results.

During a 2020 family gathering on Halloween, Maricia complained she wasn't feeling good. Over the next few days Vanessa, and Vanessa's partner, mother, two cousins, two aunts, an uncle and two grandmothers all tested positive for COVID-19. Eventually at least 13 family members caught the virus at that time and several got quite sick.

Multiple family members had to be rushed to the hospital.

Vanessa, who, like her 8-year-old daughter Maricia, suffers from asthma, was the first person to need that emergency care. "I was on the floor," Vanessa remembers. "I couldn't even say 'I'm hungry' without coughing."

Then Vanessa's 51-year-old mother, Petra Gonzales, almost blacked out.

"I got a really high fever," says Petra. "There were times when I'd fall asleep and I was OK if I didn't wake up."

In last year's COVID bout, Petra landed in the ER with severe dehydration. Soon she heard that her 71-year-old mother, Genoveva Calloway, needed hospital care for dangerously low oxygen levels and was being treated at another hospital across town.

Unlike Petra and Vanessa, who were not admitted for an extended stay at the hospital in 2020, and slowly recovered at home, Genoveva's condition was critical. She spent day after day under close supervision from doctors and nurses.

"It was really painful not to be able to help my family, because we always help each other," says Genoveva, as her voice cracked with emotion. "We are always there for each other. It was so horrible."

Finally, after nearly two weeks in the hospital, Genoveva was discharged. She was still connected to an oxygen machine as nurses shuffled her out. When Genoveva and Petra greeted each other on the street, they embraced fiercely.

"She hugged me so tight," says Genoveva. "I'll never forget that. We missed each other so much."

A year later, though, Genoveva is still recovering. She's now plagued by interstitial lung disease. That's why another round of the virus this year is a terrifying possibility.

Fortunately the family's worst fears did not unfold. Genoveva was out of town when her great-granddaughter, Maricia, brought the virus home this time, and Maricia herself recovered. The other adults did not develop symptoms they credit the COVID vaccinations they'd been able to get before the delta surge this fall. Research published by the Centers of Disease Control and Prevention concludes that vaccines offer better protection against reinfections than a natural infection. However, if a breakthrough infection occurs after someone's been vaccinated it will act like a natural "booster" and result in hybrid immunity according to Chin-Hong. He suggests most patients who are not immunocompromised wait three months until after a recent infection before getting a vaccine or a booster.

"Each exposure we have, whether it's from the infection or whether it's from the vaccine, improves our ability to combat an infection the next time around," says Dr. Julie Parsonnet, a professor of medicine and infectious diseases at Stanford University.

But Parsonnet also notes there are a lot of variables at play. First, immunity wanes. Second, the virus can mutate. Third, no vaccine provides 100% protection, and the shots may not be equally protective for everyone.

"There are certain people, including the elderly, people who are immunocompromised and people on dialysis, who really can't mount a good immune response," Parsonnet says. "They're always also going to be at risk. So every child getting vaccinated helps protect all those other people in the family that they may live with, or their neighbors."

Multi-generational living is common in Genoveva's community in the Bay Area. And her city, San Pablo, is a hot spot in Contra Costa County, where 1 out of 11 people have tested positive for the coronavirus. At the height of the pandemic, nearly 800 people tested positive in the county every day.

"Our neighborhood has three, four generations living in the same house," Genoveva says.

She says her recent booster shot allows her more peace of mind. Genoveva is looking forward to the day when her great-granddaughter and the rest of her family are finally vaccinated.

Visit link:

COVID hit this family twice, but vaccines blunted reinfections : Shots - Health News - NPR

NC Marines involved in litigation over COVID-19 vaccine mandate – Jacksonville Daily News

November 27, 2021

As the deadline for all U.S. troops to get vaccinated against COVID-19 approaches, lawsuits challenging the mandate are heating up.

Whether it's attorneys who served at local Marine bases leading litigation, or multiple North Carolina Marines involved as plaintiffs, the Jacksonville area is connected to the cases.

On Nov. 9, First Liberty Institute filed a lawsuit SEALs v. Biden in a federal court in Texas against President Joe Biden, Secretary of Defense Lloyd Austin, theDepartment of Defense (DoD) and Secretary of the Navy Carlos Del Toro on behalf of 35 Navy SEALs and special warfare service members.

The complaint, which claims a violation of the service members first amendment right to religious freedoms, saidthe plaintiffs object to receiving a COVID-19 vaccination based on their sincerely held religious beliefs."The case also argues that the SEALs are being harassedandpunished even as their religious exemptions are pending.

In a interview with The Daily News, Mike Berry, a lieutenant colonel in the Marine Corps Reserveand the lead attorney on the case, said the Navy is discriminating by not granting any religious exemptions from the COVID-19 vaccine.

There is a Navy Special Warfare Command regulation that states that even if their religious exemption is approved, it will render them medically disqualified, Berry said. Once that happens, they forfeit their special operations pay [and are] removed from the special operations community … Theyre really in a Catch 22.

Berry,whospent time at Camp Lejeune and Cherry Point while active duty, said he expects to see movement in the case in the coming weeks.

When you join the military, we all know that there are certain freedoms you give up but you dont give up your religious freedom, Berry said. We have strong protection in the law for religious freedom, even in the military.

Dale Saran, a retired Marine Corps major who was a pilot with Marine Light Attack Helicopter Squadron 269 at Marine Corps Air Station New River in the 1990s, is one of two lawyers representing a North Carolina soldier and Marine in theirlawsuitRobert v. Austin against U.S. agencies DoD, the Department of Health and Human Services and the Food and Drug Administration (FDA).

The lawsuit was originally filed in August in a Colorado court. On Nov. 2,apreliminary injunction was filed wherethe suing partiesclaimDoD is engaged in an illegal vaccination program involving all active duty, National Guard, and reserve members of the all volunteer force.

An updated complaintfiled Nov. 6saidAustin and the DoD arecoercing and forcing military members to be injected with unlicensed drugs in violation of federal law and the U.S. Constitution.

Our argument is first and foremost that its not a licensed vaccine and it cant be mandated, Saran said.

The complaint arguedthe Pfizer-BioNTech vaccine is "legally distinct"from the FDA-approved form by the name of Comirnaty. Furthermore, the complaints said"all DOD units are using the EUA Pfizer-(BioNTech) vaccine that is not yet licensed by FDA.

According to court documents, the two plaintiffs in the case are Staff Sgt. Daniel Robert of Fort Bragg and Staff Sgt. Hollie Mulvihill of Marine Corps Air Station New River.

"The military has systematically violated peoples rights," Saran said, who claimssome service members who request religious accommodation have been removed from their positions.

On Oct. 15, a class action lawsuit,Navy SEAL 1v. Biden, was filed by Liberty Counselin a Florida federal court against Biden, Austin and Security of Homeland Security Alejandro Mayorkason behalf of members from the Army, Navy, Air Force, Marine Corps and Coast Guard, as well as federal employees and civilian contractors.

The lawsuit claims plaintiffshave been unlawfully mandated to get the COVID shots or face dishonorable discharge from the military or termination from employment, said a news release from the firm.

Military plaintiffs in the lawsuit, which claims the mandate violates federal Emergency Use Authorization law and religious freedom, includeMarine Corps personnel two lieutenant colonels,one major, one captain andtwo lance corporals.

Plaintiffs are unnamed in court documents released to date; however, the major and a lance corporal are stationed in North Carolina.

The COVID shots cannot be mandatory under the federal Emergency Use Authorization law (EUA), said a Oct. 15 press release from Liberty Counsel. All of the COVID-19 shots (Pfizer, Moderna, Johnson & Johnsons Janssen) have received only EUA authorization and not full FDA approval.

In a Nov. 11 release from Liberty Counsel announcing they "filed a reply brief and additional affidavits supporting the need for immediate relief for plaintiffs," the firm doubled down on its stance.

Dr. Robert Malone, who discovered in-vitro and in-vivo RNA transfection and invented mRNA vaccines while he was at the Salk Institute in 1988, provided an affidavit in Liberty Counsels brief, the release said. Dr. Malone testified, based on the statements from the National Institutes of Health, the Centers for Disease Control, and the FDA letters concerning the vaccines, the FDA regulated product labeled COMIRNATY is the only FDA licensed SARSCoV-2 vaccine ...but it is not yet available for use in the United States."

Last month, Jacksonville congressman Greg Murphy wroteAustin objecting to the vaccine mandate for service members, calling it reprehensible that the department would consider relieving service members who refused the shot.

I worry that dismissing or refusing to deploy unvaccinated servicemembers could critically impede operational readiness and undermine U.S. national security, Murphy wrote, who is a physician. It is also highly disturbing that servicemembers who do not receive the COVID-19 vaccine will not only be excused from their duties, but they could have to retroactively pay back any bonuses received for their service or lose additional benefits.

Berry saidthe crackdown on unvaccinated service members could be detrimental to the military as a whole.

If you have to choose between your faith and serving your country, then I don't think that's a very good position for our military to be in, Berry said. I think that is actually harmful to national security to begin forcing service members to choose between their faith and their service.

Reporter Calvin Shomaker can be reached at cshomaker@gannett.com.

Original post:

NC Marines involved in litigation over COVID-19 vaccine mandate - Jacksonville Daily News

Union County Offers Additional Sites for Free COVID-19 Vaccines and Booster Shots this Week County of Union, New Jersey – UCNJ.org

November 27, 2021

The Union County Board of County Commissioners continues to encourage all Union County residents to protect themselves against the COVID-19 virus, by visiting a free Union County vaccination clinic soon. The clinics will be operating in in Elizabeth, Plainfield, Rahway, Roselle, Summit, and Union Township this coming week.

Any Union County resident can use any of these clinics, regardless of their home town.

Our free mobile vaccine clinics and permanent sites provide many opportunities to get vaccinated before gathering with family and loved ones for the December holiday season, said Commissioner Board Chairman Alexander Mirabella. We also continue to provide free COVID-19 tests for all residents.

The New Jersey Department of Health aims to fully vaccinate 85 percent of the population by years end, and we have been increasing our outreach to help meet that goal, said Commissioner Sergio Granados, who is Chair of the Commissioner Boards Public Safety Committee.

The Union County COVID-19 vaccination program covers free vaccines and booster shots, including the pediatric Pfizer vaccine for ages 5-11.

To make an appointment at any of Union Countys free COVID-19 vaccination clinics, visitucnj.org/covid19/vax.

For ages 12 and older, appointments for the Pfizer, Moderna, and J&J vaccines are available at the Union County clinic located in Downs Hall at the Kean University campus, 1000 Morris Avenue in Union Township, every Wednesday and Friday from 3:00 p.m. to 7:00 p.m., except for federal holidays.

Residents needing Moderna booster shots can also use the Union County clinic at Kean.

For ages five and older, appointments for the Pfizer vaccine are available at the Union County vaccination clinic located at the Warinanco Sports Center, at 1 Park Drive in Warinanco Park, in Roselle. This clinic is open every Thursday from 4:00 p.m. to 7:00 p.m. except for federal holidays.

Free COVID-19 vaccinations and free COVID-19 tests are also available through Union Countys mobile pop-up clinics.Sunday, November 28th Rahway Noon to 2pm: Agape Family Worship Center, 501 East Hazelwood Avenue (Pfizer vaccine for ages 12 and up, the Johnson & Johnson vaccine, and Moderna booster shots)

Monday, November 29 Summit 3pm to 6pm: Kent Place School, 42 Norwood Avenue (Pfizer for 12+ and Pfizer pediatric dose for ages 5-11)

Tuesday, November 30 Union 3pm to 6pm: Union High School, 2350 North 3rd Street (Pfizer for 12+ and Pfizer pediatric dose for ages 5-11)

Tuesday, November 30 Elizabeth 3:30 pm to 6:30 pm: Elizabeth School #50, 1000 S. Elmora Avenue (Pfizer for 12+ and Pfizer pediatric dose for ages 5-11)

Wednesday, December 1 Roselle 4:00 p.m. to 7:00 p.m.: Abraham Clark High School, 122 East 6th Avenue (Pfizer for 12+ and Pfizer pediatric dose for ages 5-11)

Saturday, December 4 Union 8:00 a.m. to 10:00 a.m.: Kean University, 1000 Morris Avenue (Pfizer vaccine for ages 12 and up, the Johnson & Johnson vaccine, and Moderna booster shots). COVID-19 emergency food supplies will also be distributed at this event.

Sunday, December 5 Summit 12:00 p.m. to 3:00 p.m. : Summit High School, 125 Kent Place Boulevard (Pfizer for 12+ and Pfizer pediatric dose for ages 5-11)

Saturday, December 18th Union 8am to 10am: Kean University, 1000 Morris Avenue. (Pfizer vaccine for ages 12 and up, the Johnson & Johnson vaccine, and Moderna booster shots). Note: COVID-19 emergency food supplies will also be distributed at this event.

Sunday, December 19th Plainfield 11am to 1pm: Gerald B. Green Plaza, 200 West Second Street (Pfizer vaccine for ages 12 and up, the Johnson & Johnson vaccine, and Moderna booster shots). Note: COVID-19 emergency food supplies will also be distributed at this event.

Union County residents seeking free COVID-19 tests can also use the Union County clinics at Kean University in Union Township and Gerald B. Green Plaza in Plainfield. For more information on these test sites visitucnj.org/covid19/covid-19-testing-options.

Vaccines and booster shots are also available on a walk-in basis at the Union County Immunization Clinic located at 40 Parker Road in Elizabeth, weekdays from 8:30 a.m. to 4:00 p.m. Please note that this clinic is available to income-eligible households.

Union County residents who are home-bound can arrange for a home vaccination visit by contacting Union Countys service provider, Mobile Medical Services. Call 1-833-256-2478 during regular weekday business hours to speak with an operator or leave a voice message, or email a callback request tovaccine@mmst.io.

For additional assistance with COVID-19 vaccines and tests, contact the Union County Vaccine Call Center at 908-613-7VAX (7829), weekdays from 8:30 a.m. to 4:30 p.m.

For information and updates on all Union County services during the COVID-19 outbreak, including free vaccination, free testing, emergency food distribution and other support services, visit ucnj.org/covid19. General information about COVID-19 is available through the New Jersey Department of Health at nj.gov/health.

# #

For all Union County programs and services visit ucnj.org, call the Public Info Line, 877-424-1234, email info@ucnj.org or use the online Contact Form.

Connect with Union County on social media.

Read the rest here:

Union County Offers Additional Sites for Free COVID-19 Vaccines and Booster Shots this Week County of Union, New Jersey - UCNJ.org

Some LGBTQ+ people worry that the COVID-19 vaccine will affect HIV medication. It won’t. – WFAE

November 27, 2021

Originally published by The 19th

Thirty-two percent of LGBTQ+ adults say they are worried that getting vaccinated against COVID-19 could negatively affect their medication for treating or preventing HIV, according to a survey by the Human Rights Campaign and a California-based market research firm. The HRC did not poll to determine what percentage of those concerned adults had actually had the shot. Experts told The 19th that there is no evidence the two treatments interact negatively.

This worry among people living with HIV/AIDs is very concerning, experts say especially among Black and Latinx LGBTQ+ people, who are disproportionately affected by HIV and who the HRC found to be more worried about COVID vaccination impacting their HIV treatment. Among Black LGBTQ+ people surveyed in the online July poll, 39 percent were worried, while 34 percent of Latinx adults said the same.

Henry Masur, director of the critical care medicine unit at the National Institutes of Health clinical center and a leading researcher in HIV/AIDS, says there is no evidence that mRNA COVID-19 vaccines or Johnson & Johnsons vaccine interact at all with HIV medications, including the preventive drug PrEP.

Theres no biological reason that I can at least imagine as to why that should interfere or interact with your anti-HIV drugs, Masur said. And in fact, there is no data that I know of, in addition to plausibility, that would suggest that there is any interaction.

People living with HIV were also included in clinical trials for all COVID-19 vaccines currently approved in the United States, per the Centers for Disease Control and Prevention.

Weve really found no indication in the data that people who are living with HIV or on PrEP, have any increased risk of side effects or negative outcomes after getting vaccinated, said David Goodman-Meza, assistant professor of infectious disease at UCLA who currently treats patients at the UCLA Vine Street clinic.

This pocket of concerned people is significant within a population that has largely trusted COVID-vaccine research. The vast majority of the roughly 1,500 adults polled by HRC were fully vaccinated 91 percent. A separate survey by the census found that most LGBTQ+ Americans polled from late September to early October had either been fully vaccinated or planned to be, and the Kaiser Family Foundation found in its COVID-19 vaccine monitor this summer that LGBTQ+ adults are more likely to be vaccinated against the coronavirus than straight and cisgender adults.

New research shows that those living with HIV who are vaccinated tend to be older. In a peer-reviewed paper expected to be published this week, Perry Halkitis, dean and professor of biostatistics and urban-global public health at Rutgers School of Public Health, and his colleagues found that vaccinated people living with HIV were older on average than those who hadnt been vaccinated. They had also been living with HIV longer.

You think about the people who have been living with HIV longer, which are often older people, which are often people who were alive prior to 1996 before antiviral therapies came along, these people see the devastation that the virus can cause, he said.

Using a national sample, Halkitis research found that 65 percent of roughly 500 participants living with HIV said they had received at least one dose of a COVID-19 vaccine between March and May.

The CDC urges people living with HIV to get vaccinated, especially because they may be more likely to get severely ill from contracting the coronavirus, though Masur also pointed out that the data proving that link is not clear. The CDC found in February that LGBTQ+ people in general report higher rates of underlying health conditions linked to severe COVID-19 symptoms.

Another piece of misinformation that has proliferated is the belief that HIV medication can protect against the virus, which has not been proven. Some clinical trials are currently examining whether HIV medications can treat the coronavirus, as well as how effective other drugs are to treat the virus, per the CDC.

Being on HIV medications isnt a shield against COVID, Goodman-Meza said.

Although the HRC found that overall, 60 percent of LGBTQ+ adults they polled have a great deal of confidence in the research and development of COVID-19 vaccines, that trust broke down by gender and racial demographics.

Among Black LGBTQ+ adults, 42 percent expressed that same confidence, while 53 percent of Latinx LGBTQ+ adults felt the same. Transgender and bisexual adults were also slightly less likely (56 percent) to trust the development of COVID-19 vaccines.

Goodman-Meza said that lack of education around vaccination ultimately means that health care providers have failed to effectively reach people where they are.

People who are Black or Latinx also have the biggest disparities in access to healthcare or HIV care, Goodman-Meza said. By not getting vaccinated, youre just kind of setting yourself up for these unwanted complications.

Public health officials must focus their messaging to reach vaccine-hesitant people living with HIV, experts say especially for gay and bisexual Black and Latino men, who are most at risk in the United States. From 2015 to 2019, HIV diagnoses among gay and bisexual men in the U.S. remained stable for Black and Latino men,while diagnoses for White men decreased by 17 percent, per the CDC.

I think theres an inherent system problem. Best care models are typically instituted in heavily White areas, Goodman-Meza said. When trying to access care, Hispanic people can face language barriers, challenges with accessing insurance, or even fear retribution because of their immigration status.

While going to their doctor or health care provider to talk about taking HIV medication and getting vaccinated is ideal, patients can also talk to counselors, social workers, and staff at local HIV/AIDS service organizations for information.

Officials should use peer education when possible to persuade Black and Latino men living with HIV to get vaccinated against COVID-19 and stress the risks of not getting vaccinated, Halkitis said.

I think that the messaging has just been one size fits all. And we know thats not true, he said.

Charleigh Flohr, senior research manager at HRC, said that more data about how LGBTQ+ people are experiencing the pandemic and how they feel about getting vaccinated is essential to reach the community and keep people healthy.

If we dont have data to convince and to demonstrate to the community that things are safe, its just going to reproduce the health equity issues, Flohr said.

Go here to see the original:

Some LGBTQ+ people worry that the COVID-19 vaccine will affect HIV medication. It won't. - WFAE

Johnson & Johnson Covid-19 Vaccine Recipients Often Shift to Other Boosters – The Wall Street Journal

November 27, 2021

We are delighted that you'd like to resume your subscription.

You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.

Please click confirm to resume now.

Read the original post:

Johnson & Johnson Covid-19 Vaccine Recipients Often Shift to Other Boosters - The Wall Street Journal

COVID-19 vaccine: Antibodies more than halved after 6 months – Medical News Today

November 27, 2021

In a new study, researchers have found that the antibodies that the body produces in response to the Pfizer-BioNTech COVID-19 vaccine reduce significantly in number in just 6 months.

The study, which has been accepted for publication in the Journal of Medical Biochemistry and is available as a preprint, also found that a persons age or sex affected the number of antibodies they developed in response to the vaccine.

The research will contribute to debates about the use of booster vaccines for COVID-19 and whether they should be limited to specific vulnerable populations or rolled out universally.

One of the great achievements of the response to the COVID-19 pandemic is scientists rapid development of safe and effective vaccines.

Initial reports of more than 90% efficacy for many of the vaccines including Pfizer-BioNTech significantly exceeded many scientists hopes.

Although the vaccines have proved slightly less effective against the Delta variant of SARS-CoV-2, they are still providing significant protection, in particular against severe cases of COVID-19.

However, scientists know that immunity acquired through vaccination typically wanes over time.

In the context of the COVID-19 pandemic, understanding several related factors including how long it takes for immunity to wane, how much it wanes by, and who is primarily affected is important for deciding when to roll out booster jabs and to whom.

In the present study, the researchers looked at data from 787 healthcare workers aged 2175 years in Verona, Italy.

The healthcare workers had received two doses of the Pfizer-BioNTech vaccine. The data included measurements of their SARS-CoV-2 antibody levels before their first vaccination, after their second vaccination, and then 1, 3, and 6 months after the second vaccination.

The researchers found that across age and sex, antibody levels reduced by more than 50% within 6 months of the second vaccination.

They also found that there were differences in the total antibody levels that participants had based on age and sex.

People under the age of 65 years had more than double the number of antibodies compared with people 65 years or older over the 6 months following the second vaccination. This followed a linear pattern as age reduced.

In addition, women had a higher number of antibodies than men, particularly if they were below the age of 65 years.

Dr. Brandon Michael Henry, a postdoctoral researcher at the Texas Biomedical Research Institute and co-leader of the study, says, [w]hile we see how well vaccines have helped keep people out of the hospital and prevent life threatening disease, antibody levels are quickly declining in all persons regardless of age and sex.

Our study provides additional evidence that booster shots for all adults will be important to keep antibody levels up so we can continue to mount an effective immune response against [SARS-CoV-2] infection and prevent COVID-19 fatalities, says Dr. Henry.

Dr. Henry suggests that the difference in antibody levels between men and women may be due to hormones. Men typically have more testosterone than women, and this hormone suppresses a persons immune system. In contrast, estrogen which is typically higher in women than in men enhances the immune system.

Dr. Henry also wonders whether chromosomes could play a part. The X chromosome carries specific genes related to immunity, and females have two X chromosomes.

Normally, only one X chromosome is active, and the other is mostly deactivated, but there is evidence that immune-related genes stay active on that redundant chromosome and help boost immune responses in women, says Dr. Henry.

Prof. Giuseppe Lippi, full professor of clinical biochemistry at the University of Verona and the corresponding author of the study, said to Medical News Today that he would expect a similar waning in immunity following a SARS-CoV-2 infection.

Vaccination is a kind of artificial infection. Therefore, antibody decline is predictably similar in people who recover from a SARS-CoV-2 infection as [it is] in vaccine recipients, said Prof. Lippi.

Prof. Lippi also agreed that the findings suggest that booster shots will be necessary for everyone.

Antibody decay is related to age and sex higher in older males but [it] displays a similar trend throughout all ages. Therefore, yes, booster doses of vaccines would be needed sooner or later for everybody, said Prof. Lippi.

Speaking to MNT, Prof. Jeffrey Townsend who is Elihu professor of biostatistics and professor of ecology and evolutionary biology at Yale School of Public Health, Connecticut, and was not involved in the study agreed that the findings suggested booster vaccinations would be necessary. Prof. Townsend is corresponding author of a study in The Lancet Microbe on the durability of SARS-CoV-2 immunity.

The decline in antibody levels with time following vaccination indicates a similarity between the waning of immunity to natural infection and the waning of immunity from vaccination and booster vaccination, he said. Other studies have demonstrated that both natural infection and vaccination are subject to decreasing efficacy in protection versus infection.

These results reinforce the need for booster vaccination for the prevention of infection by [SARS-CoV-2].

Prof. Townsend

Prof. Townsend also said that further research on waning SARS-CoV-2 immunity was necessary.

Two aspects of research should be pursued. First, studies that better characterize the benefits of vaccination and booster vaccination for the prevention of symptomaticity, severe disease, and mortality.

And second, studies that quantitatively evaluate the relative roles of antibody waning and antigenic evolution of the virus in decreasing the benefits of natural infection, vaccination, and booster vaccination, said Prof. Townsend.

For live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.

Continue reading here:

COVID-19 vaccine: Antibodies more than halved after 6 months - Medical News Today

COVID-19 Vaccines Tested in Low-Income Countries, But Distributed in Wealthy Nations – Contagionlive.com

November 27, 2021

Low- and middle-income countries have experienced COVID-19 vaccine delays and shortages. Even though vaccines and other pharmaceuticals are frequently tested in low-income countries, they often do not reap the benefits of this technology.

A study published last week in JAMA Network Open sought to examine the authorization and dispersal of COVID-19 vaccines recommended by the World Health Organization (WHO) in the countries where they were tested.

The cross-sectional study analyzed the COVID-19 vaccines authorized for emergency use by the WHO through September 7, 2021. Using the WHO COVID-19 Vaccine Tracker and Landscape and the McGill University COVID-19 Vaccine Tracker, the investigators identified all completed clinical trials for the authorized vaccines. They noted trial primary completion dates, phases, and country locations. Countries were assigned a national income group based on the 2021 World Bank historical classifications.

Using regional and national regulatory agency websites, the investigators determined whether countries hosting vaccine clinical trials also authorized them for use. They also extracted data on doses obtained from the UNICEF COVID-19 Vaccine Market Dashboard and Airfinity COVID-19 platform.

The investigators calculated the proportion of countries hosting clinical trials who had authorized any vaccine tested in their population and vaccine delivery. They determined the number of people 15 years and older who received a full vaccination series of the tested vaccine. All descriptive statistical analyses were performed using Microsoft Excel spreadsheet software.

There are 6 COVID-19 vaccines authorized for emergency use by WHO, tested in a total of 25 countries. Among 11 high-income countries who completed clinical vaccine trials, 90.9% (n=10) authorized the tested vaccine and received sufficient doses to vaccinate an average of 51.7% of their populations 15 years and older. Lower middle- and upper middle-income countries had respective authorization rates of 100% and 90.9%, with median vaccination rates of 31.0%.

Moderna completed clinical trials in 2 countries, Janssen completed trial in 10 countries, and AstraZeneca completed trials in 14. Janssen received authorization in 80% of these countries, while AstraZeneca did in 85.7%. Across all vaccine manufacturers, high-income countries received more doses to vaccinate larger proportions of their countries populations 15 and older. COVAX delivered an average of 15.4%, 48.8% and 78.8% of their vaccines in low-, lower middle-, and upper middle-income countries, respectively.

Countries of all income levels have largely authorized the vaccines their populations tested, but high-income countries continue to receive more doses to vaccinate a larger proportion of their populations.

The study authors noted These wealth-based access inequities among countries hosting trials parallel general disparities in COVID-19 vaccine access, as high-income countries have successfully procured and administered doses ahead of low- and middle-income countries.

Link:

COVID-19 Vaccines Tested in Low-Income Countries, But Distributed in Wealthy Nations - Contagionlive.com

WHO labels new Covid strain, named omicron, a ‘variant of concern,’ citing possible increased reinfection risk – CNBC

November 27, 2021

A nurse prepares the Pfizer-BioNTech Covid-19 vaccine for children for distribution in Montreal, Quebec on November 24, 2021.

ANDREJ IVANOV | AFP | Getty Images

The World Health Organization on Friday assigned the Greek letter omicron to a newly identified Covid variant in South Africa.

The U.N. health agency recognized the strain, first referred to as lineage B.1.1.529, as a variant of concern.

Health experts are deeply concerned about the transmissibility of the omicron variant given that it has an unusual constellation of mutations and a profile that is different from other variants of concern.

"Omicron, B.1.1.529, is named as a variant of concern because it has some concerning properties," Maria Van Kerkhove, the WHO's technical lead on Covid-19, said in a video published on Twitter. "This variant has a large number of mutations, and some of these mutations have some worrying characteristics."

Experts fear that the sharp upswing of Covid cases in South Africa's Gauteng province where the heavily mutated strain of the virus was first identified could mean it has greater potential to escape prior immunity than other variants. The number of omicron cases "appears to be increasing" in almost all of South Africa's provinces, the WHO reported.

The organization only labels Covid strains as variants of concern when they're more transmissible, more virulent or more adept at eluding public health measures, including vaccines and therapeutics. Data presented at a briefing Thursday hosted by South Africa's Department of Health indicates that some of omicron's mutations are connected with improved antibody resistance, which could reduce the protection offered by vaccines.

Certain mutations could also make omicron more contagious, while others haven't been reported until now, preventing researchers from understanding how they could impact the strain's behavior, according to a presentation at the briefing.

"Preliminary evidence suggests an increased risk of reinfection with this variant, as compared to other VOCs," the WHO said in a statement released Friday.

The designation of a new variant of concern coupled with mounting alarm from health officials sent global markets into a tailspin Friday. Oil prices and travel and leisure stocks took heavy losses on the news.

WHO has said it will take weeks to understand how the variant may affect diagnostics, therapeutics and vaccines.

South African scientist Tulio de Oliveira said at a media briefing Thursday that the omicron variant contains around 50 mutations but more than 30 of these are in the spike protein, the region of the protein that interacts with human cells prior to cell entry.

What's more, the receptor binding domain the part of the virus that first makes contact with our cells has 10 mutations, far greater than just two for the delta Covid variant, which spread rapidly earlier this year to become the dominant strain worldwide.

This level of mutation means it most likely came from a single patient who could not clear the virus, giving it the chance to genetically evolve. The same hypothesis was proposed for the Covid variant alpha.

"There's a lot of work that is ongoing in South Africa and in other countries to better characterize the variant itself in terms of transmissibility, in terms of severity and any impact on our countermeasures, like the use of diagnostics, therapeutics or vaccines," Van Kerkhove said. "So far there's little information, but those studies are underway."

Around 100 omicron variant genomes have been identified in South Africa, mostly in the Gauteng province. The variant has also been detected in Israel, Botswana and Hong Kong.

Many of the mutations identified in the omicron variant are linked to increased antibody resistance, which may reduce the effectiveness of vaccines and affect how the virus behaves with regard to inoculation, treatments and transmissibility, health officials have said.

Passengers wait at Frankfurt Airport.

Boris Roessler | picture alliance | Getty Images

"There are two approaches to what happens next: Wait for more scientific evidence, or act now and row back later if it wasn't required," said Sharon Peacock, professor of public health and microbiology at the University of Cambridge.

"I believe that it is better to 'go hard, go early and go fast' and apologise if mistaken, than to take an academic view that we need to reach a tipping point in evidence before action is taken. Rapid spread in South Africa could be due to super-spreader events or other factors. But there are sufficient red flags to assume the worst rather than hope for the best and take a precautionary approach," Peacock said.

The European Union, the U.K., Israel, Singapore and the U.S. are among the countries imposing travel restrictions on southern African nations.

The WHO has cautioned countries against hastily imposing travel restrictions, saying they should instead take a "risk-based scientific approach."

South Africa's foreign ministry said Friday morning that the U.K.'s decision to take precautionary measures "seems to have been rushed as even the WHO is yet to advise on the next steps."

CNBC's Elliot Smith contributed to this report.

More:

WHO labels new Covid strain, named omicron, a 'variant of concern,' citing possible increased reinfection risk - CNBC

COVID-19: Top news stories about the coronavirus pandemic on 26 November | World Economic Forum – World Economic Forum

November 27, 2021

Confirmed cases of COVID-19 have passed 260 million globally, according to Johns Hopkins University. The number of confirmed deaths has now passed 5.18 million. More than 7.81 billion vaccination doses have been administered globally, according to Our World in Data.

Eligibility for COVID-19 booster shots has been expanded in the United States, with millions of Americans getting their third dose last week.

The Czech Republic reported 27,717 new COVID-19 cases yesterday - the highest single-day total since the beginning of the pandemic.

Pfizer and MSD - known as Merck & Co in North America - have agreed to give licenses to firms in Viet Nam to produce COVID-19 treatment pills, the Vietnamese government has announced.

Three locally transmitted COVID-19 cases in Shanghai city have prompted authorities to limit tourism activities, while the city of Xuzhou has suspended some public transport after a confirmed asymptomatic case.

COVID-19 vaccination is safe for pregnant women and not associated with higher rates of complications, data released by the UK Health Security Agency showed on Thursday.

Daily new confirmed COVID-19 cases per million people in selected countries.

Image: Our World in Data

The COVID Response Alliance for Social Entrepreneurship is a coalition of 85 global leaders, hosted by the World Economic Forum. Its mission: Join hands in support of social entrepreneurs everywhere as vital first responders to the pandemic and as pioneers of a green, inclusive economic reality.

Its COVID Social Enterprise Action Agenda, outlines 25 concrete recommendations for key stakeholder groups, including funders and philanthropists, investors, government institutions, support organizations, and corporations. In January of 2021, its members launched its 2021 Roadmap through which its members will roll out an ambitious set of 21 action projects in 10 areas of work. Including corporate access and policy change in support of a social economy.

For more information see the Alliance website or its impact story here.

South African scientists have detected a new variant of COVID-19 and are working to understand its possible implications, they said yesterday.

The variant - called B.1.1.529 - has a "very unusual constellation" of mutations, which are concerning because they could help it evade the body's immune response and make it more transmissible, scientists told reporters at a news conference.

South Africa has requested an urgent meeting today of a World Health Organization working group on virus evolution to discuss the new variant.

Other countries, including India, Australia, Japan and the UK, have voiced concern, with some moving to impose travel restrictions from South Africa and some neighbouring countries.

"This is the most significant variant we have encountered to date and urgent research is underway to learn more about its transmissibility, severity and vaccine-susceptibility," the UK's Health Security Agency Chief Executive Jenny Harries said.

Countries across Europe have expanded COVID-19 vaccine booster programmes, introduced plans to vaccinate young children and increased restrictions in response to rising COVID-19 cases.

Slovakia has gone into a two-week lockdown, the Czech Republic has declared a 30-day state of emergency, which includes the early closure of bars and clubs and a ban on Christmas markets, while Germany has crossed the threshold of 100,000 COVID-19-related deaths. Germany also reported a record number of daily COVID-19 cases on Thursday - 75,961.

In France authorities have said that COVID-19 vaccine booster shots would be available to everyone aged over 18, while the Netherlands is planning for new restrictions to slow the spread of the virus. Portugal has also announced it would reimpose restrictions.

The European Union's medical regulator has approved the Pfizer/BioNTech COVID-19 vaccine for use in children aged 5- to 11-years-old. The EU Commisison has also proposed that residents will need booster shots if they wish to travel to other countries in the bloc free of tests or quarantines next summer.

It also proposed accepting all vaccines approved by the World Health Organization for travel shots. The move would allow non-essential travel to the EU from outside the bloc for those vaccinated with Chinese- or Indian-made vaccines.

Meanwhile, the WHO Regional Office for Europe and European Centre for Disease Prevention and Control (ECDC), estimates that 470,000 lives have been saved among those aged 60 years and over since the start of COVID-19 vaccination roll-out in 33 countries across the WHO European Region.

Written by

Joe Myers, Writer, Formative Content

The views expressed in this article are those of the author alone and not the World Economic Forum.

Continue reading here:

COVID-19: Top news stories about the coronavirus pandemic on 26 November | World Economic Forum - World Economic Forum

How one discredited 1998 study paved the way for today’s anti-vaxxers – Salon

November 27, 2021

Long before the COVID-19 pandemic and the concomitant vaccine, the anti-vaccination movement was mainly identified with one veryspecific myth:the idea that vaccines cause autism.

Aside from being patently offensive to neurodiverse and autistic people (including this writer), version 1.0 of the anti-vax movementwas also dangerousbecause its adherents made it easier for infectious diseases to spread. This wasn't just a theoretical fear:local measles outbreaks in places like Disneyland that occurred with greater frequency throughout the 2010s were tied to the increasing number of anti-vaxxers, who had collectively lowered the herd immunity numbers for diseases like measles which were once nearly eradicated in the United States.

Now that COVID-19 has changed the world, it is worth reexamining the legacy of that autism-related controversy, which may have proven to be the "original sin" that led us to this dismal moment in which anti-COVID-vaccination misinformation is rife.That means turning our eye to the inglorious career of a man named Andrew Wakefield.

Wakefield's wake

Once a British doctor, Wakefield is infamous for being the lead author of a 1998 case series that studied links between autism and digestive conditions and, heclaimed, documented changes in behavior in children who were given themeasles, mumps and rubella vaccine (MMR vaccine).Over time, this mutated into a claimthat MMR vaccines could cause autism, prompting an international panic.

Because Wakefield's study had been publishedin a distinguished medical journal (The Lancet), his claimsquickly circulatedand influenced millions of parents to not let their children get vaccinated at an age when, they believed erroneously, they could be at risk of developing autism. This trend persisted despite the fine print within the study: notably, itincluded no data about the MMR vaccine, its conclusions were speculative, it had been poorly designed, andthe researchers had only studied a small sample of patients. Other critics observed that, because autism is usually diagnosed at the same young age when MMR vaccines are supposed to be administered, the study could dupe impressionable parents into thinking the timing of their child's autism diagnosis was linked to the inoculation. These fears proved founded; measles outbreaks surged as more and more people followed Wakefield's uninformed advice.By2019, the United States was experiencing its worst measles outbreak since 1994.

Soon, the people who merely suspected something fishy in Wakefield's study were given more than mere clues. Other scientists were unable to reproduce Wakefield's findings, which is crucial for scientific studies to be considered valid. Then,in 2004, Wakefieldwas hit with a double whammy: An investigation by Sunday Times reporter Brian Deer demonstrated that Wakefield had financial conflicts of interest he had not disclosed when publishing his report.It was revealedthat Wakefield had established several autism-related medical businesses, but their success was predicated on establishing links between MMR vaccines and a likely-fabricated disease called "autistic entercolitis."On top of that, 10 of the 12 scientists who co-authored the paper retracted it on the grounds that "no causal link was established between MMR vaccine and autism as the data were insufficient."

By 2010 The Lancet fully retracted the paper, admitting that it was riddled with scientific errors and that the authors had behaved unethically, in no small partby studying children without the required clearances. Wakefield was ultimately stripped of his ability to practice medicine, although he continues to stand by his findings and insists he was mistreated.

Want more health and science stories in your inbox? Subscribe to Salon's weekly newsletter The Vulgar Scientist.

A direct line can be drawn between Wakefield's assertions about MMR vaccines and the rhetoric about COVID-19 vaccines (an issue where Wakefield is also anti-science, but has not emerged as a prominent voice). Studies have repeatedly found that general vaccine skepticism increased as a direct result of Wakefield's study; just last August, researchers writing for the scientific journal PLOS One again confirmed that vaccine hesitancy went up after Wakefield's paper came out.

"The Wakefield et al paper arrived at an interesting time in history," epidemiologist Dr. Ren Najera told Salon in June. "The internet was growing. The 24-hour news cycle was growing. People like Jenny McCarthy and others were becoming 'influencers.'His paper only brought to the forefront fears that many parents had: that vaccines caused developmental delays. Before 1998, you didn't have the internet as a bullhorn, or time to interview or showcase celebrities."

While hesitation about vaccines existed before Wakefield, the British doctor made it possible for misinformation to do something that had previously only occurred in the world of epidemics: achieving virality. Even after Wakefield himself sank into obscurity, other anti-vaccine activists emerged to take his place. By normalizing the practice of questioning vaccines without regard to reliable medical knowledge, they laid the foundations for the denial of the COVID-19 vaccines that is so prevalent today.

Wakefield may not be one of the so-called "disinformation dozen" social media voices today whocreate two-thirds of all anti-vaxxer content online but he is their forefather. Without Wakefield, it is hard to imagine that the anti-vaccination movement would have been so loudbefore the pandemicthat it would metastasizeduring it, to the extent thatmillions of Americans now view opposing vaccines as a crucial part of their identity.

Despite the claims made by Wakefield and others, there is no evidence that vaccines are in any way linked to autism. There is also no evidence that the COVID-19 vaccines are either unsafe or ineffective or, as some kooks claim, have microchips in them. Autismrefers to a broad range of neurological conditions that many doctors argue should not even be considered "unhealthy," and which certainly are not induced by vaccinations. Vaccineswork by training your immune system to protect the body against pathogens (microorganisms that cause disease) by either introducing a weakened or dead part or whole of that pathogen into the body, or by teaching the cells to make proteins associated with a specific pathogen so that the invader can be identified and eliminated.

Read more:

How one discredited 1998 study paved the way for today's anti-vaxxers - Salon

Page 300«..1020..299300301302..310320..»